BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25280813)

  • 21. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
    Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
    Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.
    Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q
    Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease.
    Zhang D; Damoiseaux R; Babayan L; Rivera-Meza EK; Yang Y; Bergsneider M; Wang MB; Yong WH; Kelly K; Heaney AP
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e232-e246. PubMed ID: 33000123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.
    Tateno T; Izumiyama H; Doi M; Akashi T; Ohno K; Hirata Y
    Endocr J; 2007 Dec; 54(5):777-82. PubMed ID: 17917309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
    Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
    Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
    Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
    J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells.
    Oliveira HA; Bueno AC; Pugliesi RS; da Silva Júnior RMP; de Castro M; Martins CS
    J Endocrinol Invest; 2022 May; 45(5):999-1009. PubMed ID: 34988938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.
    Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
    Endocrine; 2017 Mar; 55(3):853-860. PubMed ID: 27220856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
    Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
    Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway.
    Sun Y; Cheng J; Nie D; Fang Q; Li C; Zhang Y
    Mol Cell Endocrinol; 2024 Mar; 582():112140. PubMed ID: 38147953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ; Melmed S
    Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Oxytocin on Cell Proliferation in a Corticotroph Adenoma Cell Line.
    Lim JS; Eom YW; Lee ES; Kwon HJ; Kwon JY; Choi J; Chung CH; Jo YS; Lee EJ
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):302-313. PubMed ID: 31565883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.
    Yurekli BS; Karaca B; Kisim A; Bozkurt E; Atmaca H; Cetinkalp S; Ozgen G; Yilmaz C; Uzunoglu S; Uslu R; Saygili F
    J Endocrinol Invest; 2018 Feb; 41(2):233-240. PubMed ID: 28730425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease.
    Du L; Bergsneider M; Mirsadraei L; Young SH; Jonker JW; Downes M; Yong WH; Evans RM; Heaney AP
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8555-60. PubMed ID: 23653479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
    Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells.
    Lines KE; Filippakopoulos P; Stevenson M; Müller S; Lockstone HE; Wright B; Knapp S; Buck D; Bountra C; Thakker RV
    Endocr Relat Cancer; 2020 Mar; 27(3):163-174. PubMed ID: 31935194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 3 NR3C1 Mutations in the Pathogenesis of Pituitary ACTH Adenoma.
    Miao H; Liu Y; Lu L; Gong F; Wang L; Duan L; Yao Y; Wang R; Chen S; Mao X; Zhang D; Heaney AP; Zhu H
    Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34427636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of antisense DNA on POMC mRNA and ACTH levels in cultured human corticotroph adenoma cells.
    Woloschak M; Post K; Roberts JL
    J Endocrinol Invest; 1994 Nov; 17(10):817-9. PubMed ID: 7699217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O-GlcNAcylation Is Essential for Rapid Pomc Expression and Cell Proliferation in Corticotropic Tumor Cells.
    Massman LJ; Pereckas M; Zwagerman NT; Olivier-Van Stichelen S
    Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34418053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
    Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
    J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.